SLRX logo

Salarius Pharmaceuticals, Inc. Common Stock


SLRX: Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The Company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.


Show SLRX Financials

Consumer Interest
SEC Filings

Recent trades of SLRX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by SLRX's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of SLRX in WallStreetBets Daily Discussion


Recent insights relating to SLRX

CNBC Recommendations

Recent picks made for SLRX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in SLRX

Corporate Flights

Flights by private jets registered to SLRX